Patent · US Active

Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof

US8927509B2 · kind B2 · utility

1Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 20, 2009
Grant dateJan 6, 2015
Priority date
Expiry dateSep 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to nucleic acid aptamers that recognize and bind the complement protein C3 or its biologically active proteolytic products and methods of their use. Particularly preferred are bi-functional aptamer construct that binding specifically with C3b or iC3b, and another target protein. Use of these molecular constructs for commandeering the opsonization process is also described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.